To provide an agent for preventing or treating disorders such as schizophrenia, Alzheimer's disease, cognitive dysfunction, cognition disease, anxiety disorder (generalized anxiety disorder, panic disorder, obsessive compulsive disorder, social anxiety disorder, post traumatic stress disorder, specific phobia, acute stress disorder or the like), melancholia, drug dependence, seizure, tremor, and somnipathy or the like based on glycine capture disruption action.
The agent for preventing or treating disorders selected from a group consisting of schizophrenia, Alzheimer's disease, cognitive dysfunction, cognition disease, anxiety disorder, melancholia, drug dependence, seizure, tremor, somnipathy includes compounds expressed by formula [I] or salts or hydrates thereof which are pharmaceutically permitted as active ingredients.
SHIBATA TAKESHI
ABE KIMIYOSHI
YAMAMOTO SHUJI
KASHIWA SHUHEI
OKUBO TAKETOSHI
